173 related articles for article (PubMed ID: 4976366)
1. Vaccines produced in heteroploid cell lines--discussion.
Hull RN
Natl Cancer Inst Monogr; 1968 Dec; 29():471-2. PubMed ID: 4976366
[No Abstract] [Full Text] [Related]
2. Clinical experience with vaccines produced in the human diploid cell line WI-38.
Andzaparidze OG
Natl Cancer Inst Monogr; 1968 Dec; 29():477-84. PubMed ID: 4976367
[No Abstract] [Full Text] [Related]
3. Characteristics of primary cultures and diploid cells--technology of production.
Holper JC
Natl Cancer Inst Monogr; 1968 Dec; 29():21-31. PubMed ID: 4976359
[No Abstract] [Full Text] [Related]
4. Evidence for oncogenic properties of heteroploid cell lines--discussion.
Moore AE
Natl Cancer Inst Monogr; 1968 Dec; 29():291-2. PubMed ID: 4890060
[No Abstract] [Full Text] [Related]
5. Vaccines produced in diploid cell lines--discussion.
Perkins FT
Natl Cancer Inst Monogr; 1968 Dec; 29():495-7. PubMed ID: 5720803
[No Abstract] [Full Text] [Related]
6. Virus-associated gain and loss of proliferative and neoplastic properties of normal and virus-transformed diploid cell lines.
Yerganian G; Nell MA; Cho SS; Hayford AH; Ho T
Natl Cancer Inst Monogr; 1968 Dec; 29():241-68. PubMed ID: 4306757
[No Abstract] [Full Text] [Related]
7. Viral oncogenicity and viral vaccines--general comments.
Gerber P
Natl Cancer Inst Monogr; 1968 Dec; 29():447-8. PubMed ID: 4888932
[No Abstract] [Full Text] [Related]
8. Identification standards of primary cultures and diploid cell lines--discussion.
Stulberg CS
Natl Cancer Inst Monogr; 1968 Dec; 29():15-9. PubMed ID: 5720789
[No Abstract] [Full Text] [Related]
9. Technology of production of primary and diploid cell cultures.
Brackett RG
Natl Cancer Inst Monogr; 1968 Dec; 29():33-4. PubMed ID: 5720801
[No Abstract] [Full Text] [Related]
10. Neoplastic properties of animal cell lines. Multiple-layered perfusion cultures.
Kruse PF
Natl Cancer Inst Monogr; 1968 Dec; 29():277-8. PubMed ID: 5720797
[No Abstract] [Full Text] [Related]
11. Vaccines produced in diploid cell lines.
Ikić D
Natl Cancer Inst Monogr; 1968 Dec; 29():485-93. PubMed ID: 4976866
[No Abstract] [Full Text] [Related]
12. Cell cultures for virus vaccine production. General conclusions from the conference.
Merchant DJ
Natl Cancer Inst Monogr; 1968 Dec; 29():583-4. PubMed ID: 5720811
[No Abstract] [Full Text] [Related]
13. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
Fellowes ON
Natl Cancer Inst Monogr; 1968 Dec; 29():209-14. PubMed ID: 5720794
[No Abstract] [Full Text] [Related]
14. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
Jensen KE
Natl Cancer Inst Monogr; 1968 Dec; 29():207-8. PubMed ID: 5720793
[No Abstract] [Full Text] [Related]
15. Cells, vaccines, and the pursuit of precedent.
Hilleman MR
Natl Cancer Inst Monogr; 1968 Dec; 29():463-9. PubMed ID: 4888933
[No Abstract] [Full Text] [Related]
16. Neoplastic properties of animal cell lines--general comments.
Macpherson I
Natl Cancer Inst Monogr; 1968 Dec; 29():295-6. PubMed ID: 4976360
[No Abstract] [Full Text] [Related]
17. Identification of established cell lines with reference to karyology.
Moorhead PS
Natl Cancer Inst Monogr; 1968 Dec; 29():45-50. PubMed ID: 4305438
[No Abstract] [Full Text] [Related]
18. Neoplastic properties of animal cell lines. Methods for determining neoplastic properties--discussion.
Dawe CJ
Natl Cancer Inst Monogr; 1968 Dec; 29():229-32. PubMed ID: 5720795
[No Abstract] [Full Text] [Related]
19. Karyologic characteristics of the WI-38 diploid cell system--general comments.
Rubin BA; Minecci LC; Tint H
Natl Cancer Inst Monogr; 1968 Dec; 29():97-104. PubMed ID: 5720816
[No Abstract] [Full Text] [Related]
20. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
Vasington PJ
Natl Cancer Inst Monogr; 1968 Dec; 29():205-6. PubMed ID: 4976358
[No Abstract] [Full Text] [Related]
[Next] [New Search]
